Related Articles
Palonosetron exhibits higher total control rate compared to first‑generation serotonin antagonists and improves appetite in delayed‑phase chemotherapy‑induced nausea and vomiting
Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia
Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant
The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting
A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients